Researchers may have found a way to flip the 'itch switch' in Eczema

A test conducted on mice have proved that the itching signal is carried by a neuropeptide, which if controlled reduces itching by 80 per cent.

Published: 14th June 2018 10:11 AM  |   Last Updated: 14th June 2018 10:12 AM   |  A+A-

Image for representational purpose only

By ANI

WASHINGTON D.C.: A group of researchers has found a way to control Eczema by flipping the 'itch switch'.

The study conducted by the North Carolina State University proves that there is a neuropeptide involved in transmitting the itch signal to the brain.

They pinpointed the particular neuropeptide associated with transmitting itch signals in mice with atopic dermatitis. The work shed further light on the pathways involved in transmitting itch sensations from the peripheral (skin) to the central (spinal cord) nervous system.

"You can think of itch being transmitted from the skin to the brain as a series of switches that get flipped," said researcher Santosh Mishra.

"The signals travel from neuronal projections in the skin through the dorsal root ganglia (DRG) - which are clusters of sensory cells located at the root of the spinal nerves - then to the spinal cord. We're interested in finding out how the portion of this pathway from DRG to spinal cord works in terms of signalling itchiness in chronic skin disease", added Mishra.

Atopic dermatitis sometimes referred to as eczema, is a chronic skin condition that causes persistent itching. The main symptoms are extreme itching, small red itchy bumps, and scaly skin.

Mishra and his team looked at a protein, or cytokine called interleukin-31 (IL-31), which is overproduced in patients with atopic dermatitis and is involved in triggering itch response.

"We know that when IL-31 binds to the receptor present on neuronal projections in the skin, those neurons signal a subset of neurons in the DRG called the TRPV-1, which then signal the spinal cord," Mishra said. "We wanted to figure out which neuropeptide was involved in the 'switch' between the DRG and the spinal cord."

The team looked at the neuropeptide 'Natriuretic polypeptide B (NPPB)', which is released by TRPV-1 neurons in the DRG when IL-31 binds to receptors in the skin.

To test whether NPPB was involved in itch signalling to the spinal cord, Mishra and his team used IL-31 to trigger itchiness in mice. They found that itching decreased by 70 to 80 per cent in mice without the neuropeptide NPPB or its receptor, indicating that NPPB did play a role in the itch-signalling pathway.

"Our work shows that NPBB does act on the neurons in the spinal cord and that it plays an important role in this signalling pathway," Mishra said. "Our next steps will be to build on this work because the neurons that express NPBB can express more than one neuropeptide. Perhaps we will be able to identify another receptor involved in the link between the peripheral and central nervous system for chronic itch associated with eczema."

The research appears in Acta Dermato-Venereologica. 

Stay up to date on all the latest Health news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.